ShangBay Capital

Zeto Inc. is a medical technology company based in Santa Clara, California, focusing on revolutionizing the field of electroencephalography (EEG). Founded in 2014, Zeto has developed an innovative, FDA-cleared EEG system that features a wireless, easy-to-wear headset equipped with dry electrodes. This system addresses longstanding challenges in traditional EEG procedures, which often require extensive setup time and trained technicians. Zeto's solution allows for a streamlined process, reducing setup time from over 30 minutes to just 5 minutes while enhancing the patient experience. Complementing the headset, Zeto's cloud-based platform facilitates instant data upload, live viewing, and analytical tools, enabling remote interpretation by neurologists. The company has garnered recognition for its contributions to the field, receiving multiple awards and funding, including support from the Epilepsy Foundation and accolades from various medical innovation showcases.

Ceribell designs and manufactures medical devices for acquiring and interpreting electroencephalography (EEG) data in patients with various neurological conditions. Its flagship product, the Ceribell EEG System, includes a headband that accommodates diverse hair types and head sizes, along with a pocket-sized recorder offering clinical quality EEG and on-device display. The system enables healthcare providers to set up EEG monitoring in just six minutes, with a proprietary Brain Stethoscope function converting brainwaves into sound for easier detection of seizures.